FDA Issues Health Advisory On Pfizer’s Chantix Tablets

By JENNIFER CORBETT DOOREN
February 1, 2008 3:35 p.m.
WASHINGTON — The Food and Drug Administration said it is “increasingly likely” that Pfizer Inc.’s smoking-cessation drug Chantix may be tied to serious psychiatric symptoms. The FDA’s comment is part of a public health advisory issued Friday.
Read More!